Hence, while SMAD4 signaling may modestly reduce PD-L1 expression in tumor cells, SMAD4 functions as an indirect inducer of PD-L1 by enhancing the recruitment of tumor-infiltrating IFNγ-producing T-lymphocytes. The gene discussed is IFNG; the disease is neoplasm.